Valturna, a new combination of Diovan (valsartan) and Tekturna (aliskiren) for hypertension

December 2009

Novartis will promote Valturna, a new combination of Diovan (valsartan) and Tekturna (aliskiren) for hypertension.

Valturna will be promoted for patients who need more than one drug to control their BP...but this combo is usually not the best choice.

Both Diovan and Tekturna inhibit the renin-angiotensin aldosterone system.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote